

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.90119580 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.90119580 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.65406117 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.65406117 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.98728581 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.81987645 |
| 7 | cardiac myofibril assembly (GO:0055003) | 4.73659748 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.61522552 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.61378233 |
| 10 | complement activation, alternative pathway (GO:0006957) | 4.57149080 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45939388 |
| 12 | lysine catabolic process (GO:0006554) | 4.44497199 |
| 13 | lysine metabolic process (GO:0006553) | 4.44497199 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.43274321 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.40416501 |
| 16 | regulation of protein activation cascade (GO:2000257) | 4.34167089 |
| 17 | cell migration involved in heart development (GO:0060973) | 4.30757782 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.27618834 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 4.25387608 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 4.25387608 |
| 21 | tryptophan catabolic process (GO:0006569) | 4.25387608 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 4.25336537 |
| 23 | homocysteine metabolic process (GO:0050667) | 4.20815234 |
| 24 | regulation of complement activation (GO:0030449) | 4.17905769 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.17525880 |
| 26 | myofibril assembly (GO:0030239) | 4.13154127 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.08443113 |
| 28 | protein carboxylation (GO:0018214) | 4.08443113 |
| 29 | fatty acid beta-oxidation (GO:0006635) | 4.04916184 |
| 30 | tryptophan metabolic process (GO:0006568) | 3.99841696 |
| 31 | regulation of fibrinolysis (GO:0051917) | 3.98515055 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 3.96506091 |
| 33 | cysteine metabolic process (GO:0006534) | 3.96056153 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 3.91021205 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 3.89525177 |
| 36 | extracellular matrix assembly (GO:0085029) | 3.88676743 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 3.87257717 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 3.84588707 |
| 39 | acylglycerol homeostasis (GO:0055090) | 3.84426797 |
| 40 | triglyceride homeostasis (GO:0070328) | 3.84426797 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 3.82624723 |
| 42 | sarcomere organization (GO:0045214) | 3.82012175 |
| 43 | aspartate family amino acid catabolic process (GO:0009068) | 3.81472174 |
| 44 | atrioventricular valve morphogenesis (GO:0003181) | 3.79566581 |
| 45 | protein heterotrimerization (GO:0070208) | 3.79428987 |
| 46 | fatty acid oxidation (GO:0019395) | 3.78042463 |
| 47 | urea cycle (GO:0000050) | 3.77831885 |
| 48 | urea metabolic process (GO:0019627) | 3.77831885 |
| 49 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.77096779 |
| 50 | fatty acid catabolic process (GO:0009062) | 3.74516701 |
| 51 | bile acid metabolic process (GO:0008206) | 3.74047301 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 3.71797300 |
| 53 | muscle filament sliding (GO:0030049) | 3.70942495 |
| 54 | actin-myosin filament sliding (GO:0033275) | 3.70942495 |
| 55 | lipid oxidation (GO:0034440) | 3.70195128 |
| 56 | regulation of sequestering of triglyceride (GO:0010889) | 3.67969083 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66679030 |
| 58 | cardiac muscle contraction (GO:0060048) | 3.65924054 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 3.64784377 |
| 60 | serine family amino acid catabolic process (GO:0009071) | 3.62810144 |
| 61 | extracellular fibril organization (GO:0043206) | 3.58685504 |
| 62 | carnitine shuttle (GO:0006853) | 3.57177970 |
| 63 | ethanol oxidation (GO:0006069) | 3.56505339 |
| 64 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54226448 |
| 65 | aromatic amino acid family metabolic process (GO:0009072) | 3.53809073 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.52903726 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.52067071 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 3.49157024 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.48417302 |
| 70 | regulation of the force of heart contraction (GO:0002026) | 3.47786891 |
| 71 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.46327112 |
| 72 | cellular response to epinephrine stimulus (GO:0071872) | 3.45586788 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.43819535 |
| 74 | reverse cholesterol transport (GO:0043691) | 3.42994978 |
| 75 | stress fiber assembly (GO:0043149) | 3.39753721 |
| 76 | positive regulation of fatty acid oxidation (GO:0046321) | 3.37800808 |
| 77 | ketone body metabolic process (GO:1902224) | 3.35520724 |
| 78 | phospholipid homeostasis (GO:0055091) | 3.34515127 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.30826164 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 3.30826164 |
| 81 | macromolecular complex remodeling (GO:0034367) | 3.30826164 |
| 82 | positive regulation of lipid catabolic process (GO:0050996) | 3.30479028 |
| 83 | barbed-end actin filament capping (GO:0051016) | 3.30277630 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.28943529 |
| 85 | organic acid catabolic process (GO:0016054) | 3.28943529 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.27638429 |
| 87 | branched-chain amino acid catabolic process (GO:0009083) | 3.27442969 |
| 88 | fibrinolysis (GO:0042730) | 3.26537187 |
| 89 | actin-mediated cell contraction (GO:0070252) | 3.24904225 |
| 90 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.23906788 |
| 91 | virion attachment to host cell (GO:0019062) | 3.22668089 |
| 92 | adhesion of symbiont to host cell (GO:0044650) | 3.22668089 |
| 93 | response to epinephrine (GO:0071871) | 3.22646276 |
| 94 | negative regulation of protein activation cascade (GO:2000258) | 3.22292143 |
| 95 | epoxygenase P450 pathway (GO:0019373) | 3.21241378 |
| 96 | low-density lipoprotein particle clearance (GO:0034383) | 3.20892311 |
| 97 | fibril organization (GO:0097435) | 3.20814831 |
| 98 | valine metabolic process (GO:0006573) | 3.20298713 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.18998747 |
| 100 | actomyosin structure organization (GO:0031032) | 3.18901339 |
| 101 | glutamate metabolic process (GO:0006536) | 3.18461075 |
| 102 | biotin metabolic process (GO:0006768) | 3.18448065 |
| 103 | regulation of actin filament-based movement (GO:1903115) | 3.17476169 |
| 104 | response to mercury ion (GO:0046689) | 3.17357215 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 3.16258545 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15360744 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.15360744 |
| 108 | carnitine metabolic process (GO:0009437) | 3.14153364 |
| 109 | cardiac muscle hypertrophy (GO:0003300) | 3.13974231 |
| 110 | bile acid and bile salt transport (GO:0015721) | 3.12455636 |
| 111 | positive regulation of receptor recycling (GO:0001921) | 3.11160922 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.10850551 |
| 113 | regulation of fatty acid oxidation (GO:0046320) | 3.10669730 |
| 114 | sterol homeostasis (GO:0055092) | 3.09180598 |
| 115 | cellular glucuronidation (GO:0052695) | 3.08316248 |
| 116 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.07977444 |
| 117 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.07698207 |
| 118 | drug metabolic process (GO:0017144) | 3.06664615 |
| 119 | heme transport (GO:0015886) | 3.04718692 |
| 120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.03841047 |
| 121 | benzene-containing compound metabolic process (GO:0042537) | 3.03100580 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.03021314 |
| 123 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.02540724 |
| 124 | branched-chain amino acid metabolic process (GO:0009081) | 3.02538172 |
| 125 | cGMP-mediated signaling (GO:0019934) | 3.01391880 |
| 126 | negative regulation of sterol transport (GO:0032372) | 3.00955355 |
| 127 | negative regulation of cholesterol transport (GO:0032375) | 3.00955355 |
| 128 | phospholipid efflux (GO:0033700) | 3.00906446 |
| 129 | arginine metabolic process (GO:0006525) | 3.00871739 |
| 130 | drug catabolic process (GO:0042737) | 3.00558593 |
| 131 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.00451934 |
| 132 | regulation of plasminogen activation (GO:0010755) | 3.00004104 |
| 133 | striated muscle hypertrophy (GO:0014897) | 2.98797141 |
| 134 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.98138592 |
| 135 | collagen fibril organization (GO:0030199) | 2.97133166 |
| 136 | endocardial cushion development (GO:0003197) | 2.96891282 |
| 137 | adhesion of symbiont to host (GO:0044406) | 2.96223057 |
| 138 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.93856774 |
| 139 | venous blood vessel morphogenesis (GO:0048845) | 2.93560486 |
| 140 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.91288670 |
| 141 | dermatan sulfate metabolic process (GO:0030205) | 2.89511877 |
| 142 | basement membrane organization (GO:0071711) | 2.86227114 |
| 143 | regulation of cardioblast differentiation (GO:0051890) | 2.85215552 |
| 144 | muscle hypertrophy (GO:0014896) | 2.83369040 |
| 145 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.82866964 |
| 146 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.81438216 |
| 147 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.79329786 |
| 148 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.74722168 |
| 149 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.73343484 |
| 150 | cardiac muscle cell development (GO:0055013) | 2.73127285 |
| 151 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.72203684 |
| 152 | cardiac cell development (GO:0055006) | 2.70976430 |
| 153 | muscle tissue morphogenesis (GO:0060415) | 2.68942619 |
| 154 | cardiac muscle adaptation (GO:0014887) | 2.68930691 |
| 155 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.68930691 |
| 156 | muscle hypertrophy in response to stress (GO:0003299) | 2.68930691 |
| 157 | heart trabecula formation (GO:0060347) | 2.65303891 |
| 158 | chondroitin sulfate catabolic process (GO:0030207) | 2.64416042 |
| 159 | actin filament-based movement (GO:0030048) | 2.63322466 |
| 160 | dermatan sulfate biosynthetic process (GO:0030208) | 2.62776641 |
| 161 | striated muscle contraction (GO:0006941) | 2.62624439 |
| 162 | adherens junction assembly (GO:0034333) | 2.62154002 |
| 163 | endothelial cell morphogenesis (GO:0001886) | 2.61097997 |
| 164 | cAMP biosynthetic process (GO:0006171) | 2.58192760 |
| 165 | regulation of striated muscle contraction (GO:0006942) | 2.55748483 |
| 166 | cell communication by electrical coupling (GO:0010644) | 2.53491083 |
| 167 | focal adhesion assembly (GO:0048041) | 2.51931900 |
| 168 | cell-substrate adherens junction assembly (GO:0007045) | 2.51931900 |
| 169 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.49923636 |
| 170 | regulation of relaxation of muscle (GO:1901077) | 2.48743376 |
| 171 | cell-substrate junction assembly (GO:0007044) | 2.48490498 |
| 172 | endodermal cell differentiation (GO:0035987) | 2.47167721 |
| 173 | type B pancreatic cell proliferation (GO:0044342) | 2.46170276 |
| 174 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.45180513 |
| 175 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.44480805 |
| 176 | negative regulation of protein localization to cell surface (GO:2000009) | 2.44411054 |
| 177 | epithelial cell-cell adhesion (GO:0090136) | 2.43268472 |
| 178 | NADH metabolic process (GO:0006734) | 2.40518265 |
| 179 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.40429582 |
| 180 | cell volume homeostasis (GO:0006884) | 2.40042267 |
| 181 | fibroblast migration (GO:0010761) | 2.38060938 |
| 182 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.37646893 |
| 183 | muscle contraction (GO:0006936) | 2.36746849 |
| 184 | cardiac muscle tissue development (GO:0048738) | 2.36215978 |
| 185 | triglyceride catabolic process (GO:0019433) | 2.35265888 |
| 186 | activation of protein kinase A activity (GO:0034199) | 2.35206583 |
| 187 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.35044419 |
| 188 | keratan sulfate catabolic process (GO:0042340) | 2.35041192 |
| 189 | actin filament depolymerization (GO:0030042) | 2.34996268 |
| 190 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.34627000 |
| 191 | glomerular filtration (GO:0003094) | 2.32307184 |
| 192 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.32180149 |
| 193 | cardiac chamber formation (GO:0003207) | 2.31045052 |
| 194 | blood vessel maturation (GO:0001955) | 2.30854219 |
| 195 | regulation of cardiac muscle contraction (GO:0055117) | 2.30658958 |
| 196 | chondrocyte proliferation (GO:0035988) | 2.30475535 |
| 197 | glomerular basement membrane development (GO:0032836) | 2.29464900 |
| 198 | regulation of p38MAPK cascade (GO:1900744) | 2.29361672 |
| 199 | endothelium development (GO:0003158) | 2.28697355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.21187241 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.13547212 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89300779 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.02431895 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.87140538 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09536993 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.05692126 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.32064427 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.92368932 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85391189 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.42847238 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.20454756 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05883205 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95366126 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85152494 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83556224 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.72189137 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.71295721 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69530838 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67737316 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67737316 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67317779 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61881196 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60130405 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58562837 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57335709 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57307417 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55676278 |
| 29 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55666574 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53541284 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50125728 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.46785238 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45900903 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.44952186 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.44952186 |
| 36 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44288092 |
| 37 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.42714469 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42612908 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41673110 |
| 40 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41214675 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39934218 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38684020 |
| 43 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34618145 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34598539 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33207988 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31275197 |
| 47 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.29985613 |
| 48 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26446570 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24254750 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24174023 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22950136 |
| 52 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22636745 |
| 53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21079032 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20903251 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20473802 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20451045 |
| 57 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.20129507 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18324461 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17767871 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17372286 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16928405 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16422508 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15398590 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14517678 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13133407 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11830075 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11830075 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10668825 |
| 69 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10650424 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10215113 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07499652 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06321872 |
| 73 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05097597 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04939045 |
| 75 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.04016478 |
| 76 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.02677453 |
| 77 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02266160 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01457163 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00908742 |
| 80 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00039358 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99305448 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98330707 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97095910 |
| 84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96314619 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96049741 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95628751 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94264446 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94154820 |
| 89 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92835694 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92097765 |
| 91 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90294405 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89513482 |
| 93 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89494078 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88298582 |
| 95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87032142 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86921360 |
| 97 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86755074 |
| 98 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86216363 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85411047 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84468347 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84282353 |
| 102 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81236031 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80910142 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76866477 |
| 105 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.75356700 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75334596 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73885576 |
| 108 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.72009722 |
| 109 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70547101 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68902912 |
| 111 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68622391 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68287263 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67908297 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.67462991 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67350539 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66557798 |
| 117 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.66295313 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66127768 |
| 119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.65679528 |
| 120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.65627325 |
| 121 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.64841070 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64651673 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64507166 |
| 124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.62927159 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62794918 |
| 126 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.62477411 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61168864 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61089976 |
| 129 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.60626813 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.60216964 |
| 131 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59866589 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59543638 |
| 133 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59289699 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58091398 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57418827 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.57303172 |
| 137 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56591484 |
| 138 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.56425676 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.56111354 |
| 140 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.55990059 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.55981023 |
| 142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55571626 |
| 143 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55378192 |
| 144 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55101451 |
| 145 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.55095884 |
| 146 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54916172 |
| 147 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54879245 |
| 148 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.54357299 |
| 149 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.53444501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.80988339 |
| 2 | MP0005360_urolithiasis | 5.58556103 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.49299832 |
| 4 | MP0005365_abnormal_bile_salt | 4.38334876 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.79735083 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.43814639 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.38810023 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.22621651 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.85116286 |
| 10 | MP0003252_abnormal_bile_duct | 2.80761593 |
| 11 | MP0005670_abnormal_white_adipose | 2.52365954 |
| 12 | MP0009840_abnormal_foam_cell | 2.47809103 |
| 13 | MP0005332_abnormal_amino_acid | 2.38864382 |
| 14 | MP0010368_abnormal_lymphatic_system | 2.36155581 |
| 15 | MP0004130_abnormal_muscle_cell | 2.18532806 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.16663158 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.09264879 |
| 18 | MP0003195_calcinosis | 2.06198261 |
| 19 | MP0004510_myositis | 2.05961926 |
| 20 | MP0003646_muscle_fatigue | 2.00734184 |
| 21 | MP0005083_abnormal_biliary_tract | 1.98927536 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.98306991 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.95609542 |
| 24 | MP0000751_myopathy | 1.88517674 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.86347205 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.85285785 |
| 27 | MP0005330_cardiomyopathy | 1.81546592 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.76896069 |
| 29 | MP0005666_abnormal_adipose_tissue | 1.76713648 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.71210429 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.68239889 |
| 32 | MP0000609_abnormal_liver_physiology | 1.64085690 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.60693280 |
| 34 | MP0004215_abnormal_myocardial_fiber | 1.57319922 |
| 35 | MP0003091_abnormal_cell_migration | 1.57162820 |
| 36 | MP0000749_muscle_degeneration | 1.54091056 |
| 37 | MP0001542_abnormal_bone_strength | 1.54040903 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.51867842 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.42755441 |
| 40 | MP0005171_absent_coat_pigmentation | 1.41588402 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40130458 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.39402820 |
| 43 | MP0002933_joint_inflammation | 1.37677354 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.37122676 |
| 45 | MP0006138_congestive_heart_failure | 1.35555166 |
| 46 | MP0008775_abnormal_heart_ventricle | 1.32687759 |
| 47 | MP0005409_darkened_coat_color | 1.30798050 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.30523880 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.28340797 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.27749316 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.26297870 |
| 52 | MP0005023_abnormal_wound_healing | 1.24887121 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.23466388 |
| 54 | MP0005369_muscle_phenotype | 1.22841947 |
| 55 | MP0004272_abnormal_basement_membrane | 1.22771090 |
| 56 | MP0004087_abnormal_muscle_fiber | 1.22114811 |
| 57 | MP0003690_abnormal_glial_cell | 1.21993561 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.20894655 |
| 59 | MP0005451_abnormal_body_composition | 1.19956750 |
| 60 | MP0005385_cardiovascular_system_phenoty | 1.19223761 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.19223761 |
| 62 | MP0001661_extended_life_span | 1.18655566 |
| 63 | MP0003283_abnormal_digestive_organ | 1.18577993 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 1.17781153 |
| 65 | * MP0002972_abnormal_cardiac_muscle | 1.17459975 |
| 66 | MP0005623_abnormal_meninges_morphology | 1.16636429 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.15716583 |
| 68 | MP0003868_abnormal_feces_composition | 1.12611701 |
| 69 | * MP0005620_abnormal_muscle_contractility | 1.11476864 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.11414933 |
| 71 | MP0002971_abnormal_brown_adipose | 1.09493902 |
| 72 | MP0002269_muscular_atrophy | 1.02775047 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.02292719 |
| 74 | MP0005275_abnormal_skin_tensile | 0.98783128 |
| 75 | MP0000230_abnormal_systemic_arterial | 0.97815775 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.97773940 |
| 77 | MP0002295_abnormal_pulmonary_circulatio | 0.97642802 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.97301234 |
| 79 | MP0003186_abnormal_redox_activity | 0.97201346 |
| 80 | MP0010630_abnormal_cardiac_muscle | 0.96146901 |
| 81 | MP0000747_muscle_weakness | 0.95253376 |
| 82 | MP0003724_increased_susceptibility_to | 0.94712885 |
| 83 | MP0001764_abnormal_homeostasis | 0.93943606 |
| 84 | MP0006054_spinal_hemorrhage | 0.93113687 |
| 85 | MP0000750_abnormal_muscle_regeneration | 0.90562611 |
| 86 | MP0009697_abnormal_copulation | 0.89879449 |
| 87 | MP0003045_fibrosis | 0.89793792 |
| 88 | MP0002060_abnormal_skin_morphology | 0.87433102 |
| 89 | MP0000733_abnormal_muscle_development | 0.87329133 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.86351495 |
| 91 | MP0005165_increased_susceptibility_to | 0.85894027 |
| 92 | MP0001756_abnormal_urination | 0.85232310 |
| 93 | MP0003011_delayed_dark_adaptation | 0.84553220 |
| 94 | MP0005390_skeleton_phenotype | 0.84310124 |
| 95 | MP0004085_abnormal_heartbeat | 0.83778007 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.83251942 |
| 97 | MP0002254_reproductive_system_inflammat | 0.83161390 |
| 98 | MP0000604_amyloidosis | 0.82230323 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.81939334 |
| 100 | MP0005334_abnormal_fat_pad | 0.81252938 |
| 101 | MP0003279_aneurysm | 0.80369581 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.79702993 |
| 103 | MP0000249_abnormal_blood_vessel | 0.79492953 |
| 104 | MP0000920_abnormal_myelination | 0.78020592 |
| 105 | MP0004484_altered_response_of | 0.77815582 |
| 106 | MP0005388_respiratory_system_phenotype | 0.77298784 |
| 107 | MP0002133_abnormal_respiratory_system | 0.77298784 |
| 108 | MP0000598_abnormal_liver_morphology | 0.77286241 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.77272566 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.77011638 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.76891319 |
| 112 | MP0004858_abnormal_nervous_system | 0.76738158 |
| 113 | MP0009763_increased_sensitivity_to | 0.75605967 |
| 114 | MP0003329_amyloid_beta_deposits | 0.75409036 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.75362435 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.75261646 |
| 117 | MP0005647_abnormal_sex_gland | 0.74691003 |
| 118 | MP0005535_abnormal_body_temperature | 0.74180593 |
| 119 | MP0003828_pulmonary_edema | 0.73437776 |
| 120 | MP0001614_abnormal_blood_vessel | 0.72919536 |
| 121 | MP0009115_abnormal_fat_cell | 0.72783081 |
| 122 | MP0001958_emphysema | 0.72773866 |
| 123 | MP0003075_altered_response_to | 0.72723081 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70768598 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.68939198 |
| 126 | * MP0000343_altered_response_to | 0.67840614 |
| 127 | MP0000266_abnormal_heart_morphology | 0.67221376 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.67174640 |
| 129 | MP0009764_decreased_sensitivity_to | 0.66307037 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.65860532 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.65821933 |
| 132 | MP0004233_abnormal_muscle_weight | 0.65412553 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.64800733 |
| 134 | MP0000759_abnormal_skeletal_muscle | 0.64736660 |
| 135 | MP0005164_abnormal_response_to | 0.63779745 |
| 136 | MP0002128_abnormal_blood_circulation | 0.63616683 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.63267694 |
| 138 | MP0001533_abnormal_skeleton_physiology | 0.62893042 |
| 139 | MP0004883_abnormal_blood_vessel | 0.61386695 |
| 140 | MP0000462_abnormal_digestive_system | 0.61069294 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.59996106 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.57697997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.55655381 |
| 2 | Protrusio acetabuli (HP:0003179) | 5.52887778 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.10645542 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.08449139 |
| 5 | Aortic aneurysm (HP:0004942) | 5.07022108 |
| 6 | Premature rupture of membranes (HP:0001788) | 4.85501937 |
| 7 | Xanthomatosis (HP:0000991) | 4.83804624 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.57128580 |
| 9 | Complement deficiency (HP:0004431) | 4.54092597 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.50085139 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.23540680 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 4.09465239 |
| 13 | Hyperammonemia (HP:0001987) | 4.04243029 |
| 14 | Aortic dissection (HP:0002647) | 4.03979641 |
| 15 | Ketosis (HP:0001946) | 4.02644684 |
| 16 | Hyperglycinuria (HP:0003108) | 3.85341872 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.76863079 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.76303113 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 3.75534978 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73871385 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.73871385 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.70767729 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.67208332 |
| 24 | Bundle branch block (HP:0011710) | 3.59567895 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 3.51822844 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.48863993 |
| 27 | Hyperglycinemia (HP:0002154) | 3.42660683 |
| 28 | Cerebral aneurysm (HP:0004944) | 3.39222255 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.34654798 |
| 30 | Ketoacidosis (HP:0001993) | 3.32817159 |
| 31 | Muscle fiber splitting (HP:0003555) | 3.29133632 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.28525890 |
| 33 | Epidermoid cyst (HP:0200040) | 3.25279597 |
| 34 | Spinal rigidity (HP:0003306) | 3.24234472 |
| 35 | Vascular tortuosity (HP:0004948) | 3.23959676 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19960171 |
| 37 | Sudden death (HP:0001699) | 3.14386231 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.13932548 |
| 39 | Abnormality of complement system (HP:0005339) | 3.13345352 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 3.09693592 |
| 41 | Joint hemorrhage (HP:0005261) | 3.05805782 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.01357377 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 2.98750645 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98253986 |
| 45 | Myoglobinuria (HP:0002913) | 2.97395378 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.96151515 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96151515 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.92582010 |
| 49 | Supraventricular tachycardia (HP:0004755) | 2.92168187 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.89724320 |
| 51 | Aneurysm (HP:0002617) | 2.86723890 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.81771609 |
| 53 | Round ear (HP:0100830) | 2.79848163 |
| 54 | Soft skin (HP:0000977) | 2.79163168 |
| 55 | Ankle contracture (HP:0006466) | 2.78999310 |
| 56 | Abnormal atrioventricular conduction (HP:0005150) | 2.77989890 |
| 57 | Ventricular tachycardia (HP:0004756) | 2.76522573 |
| 58 | Aortic regurgitation (HP:0001659) | 2.75816065 |
| 59 | Dilatation of the ascending aorta (HP:0005111) | 2.72546660 |
| 60 | Exercise-induced myalgia (HP:0003738) | 2.71043301 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.69091738 |
| 62 | Subaortic stenosis (HP:0001682) | 2.69091738 |
| 63 | Bladder diverticulum (HP:0000015) | 2.68685029 |
| 64 | Arterial tortuosity (HP:0005116) | 2.68544321 |
| 65 | Shallow orbits (HP:0000586) | 2.67236782 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.65426884 |
| 67 | Hypercholesterolemia (HP:0003124) | 2.64838164 |
| 68 | Wormian bones (HP:0002645) | 2.64833688 |
| 69 | Fat malabsorption (HP:0002630) | 2.64565261 |
| 70 | Skin nodule (HP:0200036) | 2.64564081 |
| 71 | Heart block (HP:0012722) | 2.62511223 |
| 72 | Neck muscle weakness (HP:0000467) | 2.61565512 |
| 73 | Delayed CNS myelination (HP:0002188) | 2.57915641 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.57333067 |
| 75 | Cervical subluxation (HP:0003308) | 2.54872822 |
| 76 | Mitral regurgitation (HP:0001653) | 2.53284367 |
| 77 | Cerebral edema (HP:0002181) | 2.51927894 |
| 78 | Mitral valve prolapse (HP:0001634) | 2.46540016 |
| 79 | Metabolic acidosis (HP:0001942) | 2.46536322 |
| 80 | Obstructive sleep apnea (HP:0002870) | 2.46454502 |
| 81 | Lethargy (HP:0001254) | 2.45320565 |
| 82 | Fragile skin (HP:0001030) | 2.45019660 |
| 83 | Calf muscle hypertrophy (HP:0008981) | 2.44925417 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.43953620 |
| 85 | Myocardial infarction (HP:0001658) | 2.41882081 |
| 86 | Hypoplasia of the iris (HP:0007676) | 2.39924566 |
| 87 | Polycythemia (HP:0001901) | 2.38437864 |
| 88 | Lipoatrophy (HP:0100578) | 2.38400107 |
| 89 | Ventricular arrhythmia (HP:0004308) | 2.38329719 |
| 90 | Lymphangioma (HP:0100764) | 2.37839077 |
| 91 | Esophageal varix (HP:0002040) | 2.37676719 |
| 92 | Cholelithiasis (HP:0001081) | 2.37528824 |
| 93 | Abnormal gallbladder morphology (HP:0012437) | 2.37522979 |
| 94 | Atrophic scars (HP:0001075) | 2.37147966 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.35231304 |
| 96 | Amyloidosis (HP:0011034) | 2.33350682 |
| 97 | Wrist flexion contracture (HP:0001239) | 2.32093765 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.31874809 |
| 99 | Pulmonary artery stenosis (HP:0004415) | 2.31111634 |
| 100 | Increased connective tissue (HP:0009025) | 2.30111532 |
| 101 | Cerebral hemorrhage (HP:0001342) | 2.30108007 |
| 102 | Exercise-induced muscle cramps (HP:0003710) | 2.29501995 |
| 103 | Syncope (HP:0001279) | 2.29003956 |
| 104 | Vascular calcification (HP:0004934) | 2.26719217 |
| 105 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.26668533 |
| 106 | Gout (HP:0001997) | 2.25462344 |
| 107 | Rhabdomyolysis (HP:0003201) | 2.24107657 |
| 108 | Blue sclerae (HP:0000592) | 2.22090259 |
| 109 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21774712 |
| 110 | Joint stiffness (HP:0001387) | 2.20652593 |
| 111 | Nemaline bodies (HP:0003798) | 2.20260732 |
| 112 | Vomiting (HP:0002013) | 2.19023259 |
| 113 | Hyperbilirubinemia (HP:0002904) | 2.18312015 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.17852444 |
| 115 | Ectopia lentis (HP:0001083) | 2.16416186 |
| 116 | Atrial fibrillation (HP:0005110) | 2.13772304 |
| 117 | Generalized aminoaciduria (HP:0002909) | 2.13438482 |
| 118 | Muscle fiber inclusion bodies (HP:0100299) | 2.11887597 |
| 119 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.11362980 |
| 120 | Broad metatarsal (HP:0001783) | 2.10005453 |
| 121 | Aortic valve stenosis (HP:0001650) | 2.09759900 |
| 122 | Overgrowth (HP:0001548) | 2.09747027 |
| 123 | Atrioventricular block (HP:0001678) | 2.09617579 |
| 124 | Hepatocellular carcinoma (HP:0001402) | 2.09253112 |
| 125 | Hip contracture (HP:0003273) | 2.08878468 |
| 126 | Palpitations (HP:0001962) | 2.07374660 |
| 127 | Abnormality of nucleobase metabolism (HP:0010932) | 2.06951937 |
| 128 | Abnormal cartilage morphology (HP:0002763) | 2.06512631 |
| 129 | Abnormal gallbladder physiology (HP:0012438) | 2.05798892 |
| 130 | Cholecystitis (HP:0001082) | 2.05798892 |
| 131 | Biconcave vertebral bodies (HP:0004586) | 2.05292102 |
| 132 | Slender build (HP:0001533) | 2.04914945 |
| 133 | Prolonged QT interval (HP:0001657) | 2.04538870 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 2.04069830 |
| 135 | Scapular winging (HP:0003691) | 2.03281886 |
| 136 | Abnormality of dentin (HP:0010299) | 2.02989877 |
| 137 | Vertebral compression fractures (HP:0002953) | 2.02072402 |
| 138 | Bradycardia (HP:0001662) | 2.01306292 |
| 139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01117441 |
| 140 | Peritonitis (HP:0002586) | 2.00257491 |
| 141 | Steatorrhea (HP:0002570) | 2.00058238 |
| 142 | Neonatal short-limb short stature (HP:0008921) | 1.99384573 |
| 143 | Difficulty running (HP:0009046) | 1.97756402 |
| 144 | Hydroxyprolinuria (HP:0003080) | 1.97397458 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 1.97397458 |
| 146 | Spondylolisthesis (HP:0003302) | 1.97366430 |
| 147 | Glomerulonephritis (HP:0000099) | 1.97034630 |
| 148 | Hemorrhage of the eye (HP:0011885) | 1.96954371 |
| 149 | Abnormality of the calf musculature (HP:0001430) | 1.96293917 |
| 150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95112694 |
| 151 | Asymmetric septal hypertrophy (HP:0001670) | 1.94955078 |
| 152 | Malnutrition (HP:0004395) | 1.93819966 |
| 153 | Joint laxity (HP:0001388) | 1.92869350 |
| 154 | Lower limb amyotrophy (HP:0007210) | 1.91898459 |
| 155 | Spontaneous abortion (HP:0005268) | 1.91647247 |
| 156 | Follicular hyperkeratosis (HP:0007502) | 1.91071051 |
| 157 | Mitral stenosis (HP:0001718) | 1.90771712 |
| 158 | Primary atrial arrhythmia (HP:0001692) | 1.90157138 |
| 159 | Sensorimotor neuropathy (HP:0007141) | 1.89609884 |
| 160 | Stridor (HP:0010307) | 1.89583926 |
| 161 | EMG: myopathic abnormalities (HP:0003458) | 1.89409017 |
| 162 | Ulnar bowing (HP:0003031) | 1.88440487 |
| 163 | Increased muscle lipid content (HP:0009058) | 1.86955178 |
| 164 | Venous abnormality (HP:0002624) | 1.86240754 |
| 165 | Axonal loss (HP:0003447) | 1.85338857 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.84968294 |
| 167 | EMG: neuropathic changes (HP:0003445) | 1.84877146 |
| 168 | Hypertriglyceridemia (HP:0002155) | 1.84389883 |
| 169 | Infantile muscular hypotonia (HP:0008947) | 1.83839342 |
| 170 | Emphysema (HP:0002097) | 1.83417286 |
| 171 | Myotonia (HP:0002486) | 1.82328984 |
| 172 | Wide anterior fontanel (HP:0000260) | 1.80722382 |
| 173 | Limited hip movement (HP:0008800) | 1.80639489 |
| 174 | Supraventricular arrhythmia (HP:0005115) | 1.80119472 |
| 175 | Abnormality of the foot musculature (HP:0001436) | 1.79642122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.79641019 |
| 2 | TIE1 | 3.83606427 |
| 3 | TTN | 3.29547988 |
| 4 | MYLK | 3.07815726 |
| 5 | PDK2 | 2.52615619 |
| 6 | TRIB3 | 2.51327396 |
| 7 | SIK1 | 2.50247101 |
| 8 | ERN1 | 2.39741016 |
| 9 | FGFR4 | 2.16865823 |
| 10 | PDK4 | 2.14733216 |
| 11 | PDK3 | 2.14733216 |
| 12 | PHKG1 | 2.03737319 |
| 13 | PHKG2 | 2.03737319 |
| 14 | TESK1 | 2.02862017 |
| 15 | EPHB1 | 2.00076197 |
| 16 | KDR | 1.99455073 |
| 17 | PIK3CA | 1.88200940 |
| 18 | CDC42BPA | 1.84288031 |
| 19 | LMTK2 | 1.78780308 |
| 20 | INSRR | 1.74134669 |
| 21 | STK39 | 1.73051664 |
| 22 | TGFBR2 | 1.71650532 |
| 23 | OBSCN | 1.71006990 |
| 24 | WNK4 | 1.66696842 |
| 25 | PRPF4B | 1.64753085 |
| 26 | MAP3K6 | 1.59674407 |
| 27 | LIMK1 | 1.50562931 |
| 28 | TYRO3 | 1.46475099 |
| 29 | FGFR2 | 1.45966426 |
| 30 | RIPK1 | 1.43831778 |
| 31 | PINK1 | 1.43489660 |
| 32 | PKN2 | 1.36756890 |
| 33 | PKN1 | 1.34592078 |
| 34 | DMPK | 1.33055704 |
| 35 | MAPK12 | 1.30958450 |
| 36 | PRKAA2 | 1.22536088 |
| 37 | CAMK1D | 1.19216801 |
| 38 | MAP3K3 | 1.17755087 |
| 39 | MARK2 | 1.16535207 |
| 40 | MST1R | 1.06564966 |
| 41 | ERBB4 | 1.06448655 |
| 42 | MET | 1.06284693 |
| 43 | PAK3 | 1.05058635 |
| 44 | CAMK1 | 1.04984400 |
| 45 | PRKD1 | 1.04640209 |
| 46 | EPHB2 | 1.02150873 |
| 47 | PTK2B | 1.00874060 |
| 48 | LATS1 | 1.00762596 |
| 49 | MAPKAPK3 | 0.99266535 |
| 50 | PTK6 | 0.97150381 |
| 51 | MAP3K7 | 0.95747862 |
| 52 | PDPK1 | 0.92225782 |
| 53 | PDGFRA | 0.92052876 |
| 54 | CSK | 0.92041213 |
| 55 | STK38 | 0.88359138 |
| 56 | CAMK1G | 0.88144820 |
| 57 | RPS6KA2 | 0.88010059 |
| 58 | PIK3CG | 0.87713529 |
| 59 | LATS2 | 0.86732029 |
| 60 | OXSR1 | 0.82551054 |
| 61 | MARK1 | 0.82342467 |
| 62 | MAP2K3 | 0.82252805 |
| 63 | TAOK2 | 0.79919534 |
| 64 | ABL2 | 0.79568983 |
| 65 | GSK3A | 0.79387780 |
| 66 | RPS6KL1 | 0.77887581 |
| 67 | RPS6KC1 | 0.77887581 |
| 68 | NTRK1 | 0.75940484 |
| 69 | STK38L | 0.75580742 |
| 70 | ICK | 0.74214002 |
| 71 | PRKAA1 | 0.74088097 |
| 72 | ROCK1 | 0.71548559 |
| 73 | TAOK1 | 0.71338558 |
| 74 | CAMK2D | 0.70973915 |
| 75 | CAMK2G | 0.70649559 |
| 76 | MAPK7 | 0.70405953 |
| 77 | MAP2K4 | 0.68447932 |
| 78 | KIT | 0.67278762 |
| 79 | PRKCH | 0.66728550 |
| 80 | TNK2 | 0.66689535 |
| 81 | NEK9 | 0.63392830 |
| 82 | RPS6KA6 | 0.62280843 |
| 83 | ZAP70 | 0.61888094 |
| 84 | FER | 0.61276073 |
| 85 | MAPK11 | 0.59416169 |
| 86 | JAK1 | 0.58799779 |
| 87 | PAK4 | 0.58573577 |
| 88 | DAPK3 | 0.56749729 |
| 89 | SGK223 | 0.56590696 |
| 90 | SGK494 | 0.56590696 |
| 91 | PAK2 | 0.56231638 |
| 92 | GRK5 | 0.55994196 |
| 93 | PRKACG | 0.55448369 |
| 94 | BMX | 0.55002552 |
| 95 | DAPK2 | 0.54698712 |
| 96 | DDR2 | 0.53454799 |
| 97 | EEF2K | 0.52385307 |
| 98 | MOS | 0.52214086 |
| 99 | MAPK4 | 0.51653098 |
| 100 | PDGFRB | 0.51372295 |
| 101 | CAMK2B | 0.50815239 |
| 102 | PDK1 | 0.50525721 |
| 103 | MAPK15 | 0.50111503 |
| 104 | AKT3 | 0.49047723 |
| 105 | MAP3K11 | 0.48008960 |
| 106 | PRKG2 | 0.47165569 |
| 107 | TBK1 | 0.46314279 |
| 108 | GRK7 | 0.46121777 |
| 109 | TYK2 | 0.45671458 |
| 110 | ADRBK1 | 0.44026956 |
| 111 | MAP2K1 | 0.43860751 |
| 112 | HIPK2 | 0.43686926 |
| 113 | WNK1 | 0.42719449 |
| 114 | ILK | 0.42428923 |
| 115 | JAK2 | 0.42266212 |
| 116 | CAMK4 | 0.42142176 |
| 117 | PTK2 | 0.40624970 |
| 118 | PRKACB | 0.40086237 |
| 119 | PRKD3 | 0.39696278 |
| 120 | TAOK3 | 0.37677627 |
| 121 | PAK6 | 0.37654173 |
| 122 | NTRK3 | 0.36035694 |
| 123 | ROCK2 | 0.35499520 |
| 124 | TRPM7 | 0.35471801 |
| 125 | SGK3 | 0.34795332 |
| 126 | EPHA3 | 0.34523490 |
| 127 | MTOR | 0.34183288 |
| 128 | MAP2K2 | 0.33733051 |
| 129 | MUSK | 0.33240481 |
| 130 | PRKCZ | 0.32747031 |
| 131 | CAMK2A | 0.32433999 |
| 132 | PRKD2 | 0.32378659 |
| 133 | PRKACA | 0.31921292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58603430 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20513725 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97379206 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.90154603 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.87751716 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.82100862 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68617598 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66113434 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56201875 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51784131 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49542709 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.34803141 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30413414 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.30275517 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28048404 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24506913 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15133693 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.96261273 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95263493 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94874559 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82544896 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.78046612 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74120227 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.73913339 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70883517 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68278488 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67897497 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64863187 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56972737 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56812089 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55872994 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55501547 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48819914 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.47413564 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45633701 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44987268 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42263639 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38437199 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.38000858 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33106130 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31653696 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29238751 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25701533 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.25662228 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24343401 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19922071 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17151895 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14641301 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14107700 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13901811 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08848374 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08677539 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06974698 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06649730 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02919812 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02856881 |
| 57 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.01163297 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.00798966 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99683741 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.99265379 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99180220 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99081907 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.98498479 |
| 64 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97467468 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96408622 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92464569 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90979479 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90667819 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87910696 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.86445939 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85586741 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85392972 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83765724 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83611431 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81913115 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80809663 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.80343132 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.79764507 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78829907 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78067399 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77410043 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77107704 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76358402 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74067596 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.73854720 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73686777 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71913181 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.71646965 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.69998715 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69697769 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.69283715 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64721936 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63491073 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63263848 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63235093 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63161822 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61571132 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61065393 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60232841 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60089957 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59252170 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58847022 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58013050 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56299561 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54061157 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53758495 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.53634972 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51886633 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51530546 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50160832 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.49465016 |
| 112 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48902921 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48054037 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47831885 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47098257 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45674056 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.45578988 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.45318068 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44459858 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.43271167 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42991736 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.42733302 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42675053 |
| 124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41833400 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41739091 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40655692 |
| 127 | Morphine addiction_Homo sapiens_hsa05032 | 0.40416600 |
| 128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40149414 |
| 129 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39513495 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39243852 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38426952 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.38422915 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38104046 |
| 134 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38064685 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37720543 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37120004 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37030585 |
| 138 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36664574 |
| 139 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36033882 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34987232 |
| 141 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33572181 |
| 142 | Parkinsons disease_Homo sapiens_hsa05012 | 0.30169233 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30048247 |
| 144 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24871982 |
| 145 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23075116 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22845023 |
| 147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20852353 |
| 148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19769860 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19377729 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | 0.14526512 |
| 151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10902966 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10812997 |
| 153 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.09501403 |
| 154 | Amoebiasis_Homo sapiens_hsa05146 | 0.08587067 |
| 155 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08382076 |
| 156 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04673913 |
| 157 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03398072 |
| 158 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0537305 |
| 159 | Tight junction_Homo sapiens_hsa04530 | -0.0530260 |
| 160 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0357040 |
| 161 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0103402 |

